| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 |
| Total Revenue | 27 | 28 | 57 | 34 |
| Cost of Revenue | 5 | 13 | 14 | 12 |
|
| Gross Profit | 22 | 15 | 43 | 22 |
|
| Operating Expenses |
| Research Development |
-
|
-
|
-
|
-
|
| Selling General and Administrative | 295 | 292 | 273 | 249 |
| Non Recurring |
-
|
-
|
-
|
-
|
| Others | 11 | 11 | 10 | 12 |
| |
| Total Operating Expenses |
-
|
-
|
-
|
-
|
|
|
| Operating Income or Loss | (284) | (287) | (240) | (239) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net |
-
|
-
| (0) | 0 |
| Earnings Before Interest And Taxes | (340) | (287) | (240) | (239) |
| Interest Expense |
-
| 53 | 45 | 18 |
| Income Before Tax | (340) | (340) | (285) | (257) |
| Income Tax Expense |
-
|
-
|
-
|
-
|
| Minority Interest |
-
|
-
|
-
|
-
|
| |
| Net Income From Continuing Ops | (340) | (340) | (285) | (257) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
-
|
-
|
| Extraordinary Items |
-
|
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
-
|
|
|
| Net Income | (340) | (340) | (285) | (257) |
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
|
|
| Net Income Applicable To Common Shares | ($340) | ($340) | ($285) | ($257) |
0.51% Nasdaq 
Income Statement
